open access

Vol 8, No 1 (2015)
CASE REPORTS
Published online: 2015-02-24
Get Citation

Intracranial hemorrhage in a patient with severe hemophilia — case report

Łukasz Sokołowski, Paulina Sobieszak-Skura, Barbara Masłowska
Journal of Transfusion Medicine 2015;8(1):37-41.

open access

Vol 8, No 1 (2015)
CASE REPORTS
Published online: 2015-02-24

Abstract

Hemophilia is a genetically inherited bleeding disorder, caused by deficiency or lack of clotting factor VIII (hemophilia A) or IX (hemophilia B). Treatment of bleeding in the course of the disease is based on the substitution of coagulation factors. The prognosis and treatment is more difficult in patients with elevated level of inhibitors of coagulation factor VIII or IX. Hemorrhage into the central nervous system (CNS) is one of the most serious complications of hemophilia, requiring intensive treatment and monitoring of the patient. Patient, 63 year old male with severe haemophilia A was admitted to the Department of Neurology and Stroke Treatment due to headaches and weakness of left limbs. We performed CT-scan and revealed hemorrhage in the right parieto-temporal region of brain, 65 × 45 mm in diameter, with edema of the right hemisphere. During the first day of hospitalization clotting factor activity was 85.3%, and the inhibitor activity — 1.3 Bethesda Units (BU/mL). Despite substitution treatment with high doses of concentrated factor VIII, in the control CT-scan of patients brain we found enlargement of the hemorrhage. It was decided to include bypassing agents (BPA) in the treatment. General and neurological condition of the patient improved and reduction of hemorrhage was revealed in the next CT-scan.

Abstract

Hemophilia is a genetically inherited bleeding disorder, caused by deficiency or lack of clotting factor VIII (hemophilia A) or IX (hemophilia B). Treatment of bleeding in the course of the disease is based on the substitution of coagulation factors. The prognosis and treatment is more difficult in patients with elevated level of inhibitors of coagulation factor VIII or IX. Hemorrhage into the central nervous system (CNS) is one of the most serious complications of hemophilia, requiring intensive treatment and monitoring of the patient. Patient, 63 year old male with severe haemophilia A was admitted to the Department of Neurology and Stroke Treatment due to headaches and weakness of left limbs. We performed CT-scan and revealed hemorrhage in the right parieto-temporal region of brain, 65 × 45 mm in diameter, with edema of the right hemisphere. During the first day of hospitalization clotting factor activity was 85.3%, and the inhibitor activity — 1.3 Bethesda Units (BU/mL). Despite substitution treatment with high doses of concentrated factor VIII, in the control CT-scan of patients brain we found enlargement of the hemorrhage. It was decided to include bypassing agents (BPA) in the treatment. General and neurological condition of the patient improved and reduction of hemorrhage was revealed in the next CT-scan.

Get Citation

Keywords

hemophilia A, bypassing agents (BPA), intercranial hemorrhage

About this article
Title

Intracranial hemorrhage in a patient with severe hemophilia — case report

Journal

Journal of Transfusion Medicine

Issue

Vol 8, No 1 (2015)

Pages

37-41

Published online

2015-02-24

Bibliographic record

Journal of Transfusion Medicine 2015;8(1):37-41.

Keywords

hemophilia A
bypassing agents (BPA)
intercranial hemorrhage

Authors

Łukasz Sokołowski
Paulina Sobieszak-Skura
Barbara Masłowska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Journal of Transfusion Medicine dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl